We first examined markers for cell proliferation.
Next, we examined markers for differentiation after 1, 3 and 5 days of BMP treatment.
Given that the presence of microbial invasion of the amniotic cavity (MIAC) in cases may influence associations, we examined markers for allele and genotype difference between cases with and without MIAC (Table 6).
The predictive role of all examined markers for paclitaxel treatment were also evaluated, performing Cox model analysis with interaction terms of each gene with treatment (paclitaxel vs. no paclitaxel).
The second follow-up study examined markers for chronic diseases affecting cardiovascular, musculoskeletal, and mental health in the cohort of young adults who took part in the initial trial.
11, 12, 16 We examined markers for early endosomes by confocal immunofluorescence microscopy, but saw no differences in their appearance or localization among control and SPG15 fibroblasts; the endoplasmic reticulum also appeared normal (Fig. 3A and Fig. S5).
Cox proportional hazard regression analyses, adjusted for treatment, were performed for the examined markers, as well as for the combination of HER2/ TOP2A gene status to assess prognostic significance on DFS and OS.
Using fluorescent-labeled oligonucleotide primers, we genotyped 91 female T. pallidus collected in nine localities and 46 female C. juglandicola collected in 4 localities and found 15 of the examined markers to be polymorphic for T. pallidus and 12 of the examined markers to be polymorphic for C. juglandicola.
Although the CSF is a more relevant source to examine diagnostic markers for AD, plasma offers a distinct advantage as it is more easily accessible for clinical use in monitoring disease progression and therapeutic interventions.
Many studies have been published that examine genetic markers for the prediction of statin efficacy [ 26].
